{"title":"人类骨骼疾病的放射性同位素骨图动力学研究。","authors":"N S MACDONALD","doi":"10.2172/129479","DOIUrl":null,"url":null,"abstract":"Radioactive strontium can serve as a tracer to gain information concerning calcium metabolism in human subjects. Gamma-emitting Sr{sup 85} is used rather than the much more hazardous, beta-emitting Sr{sup 89} and Sr{sup 90}. (ca{sup 47} -- the ideal tracer for normal calcium -- is quite expensive and difficult to procure.) Very significant information may be obtained merely by measuring and recording the changes in radioactivity in various body areas during the first hour after intravenous injection of the bone-seeking radioisotope. This is accomplished by placing a lead-shielded gamma-scintillation detector in contact with the skin over the sites of interest and recording the activities on a scaler or ratemeter. The activity versus time curves so obtained are called radioisotope osteograms. Data were presented which indicated that Sr{sup 85} osteograms for patients afflicted with osteoporosis, Paget`s disease, tumor metastases to bone, and possibly multiple myeloma, differ significantly from those obtained from subjects with no skeletal abnormalities. Some interpretations of these deviations were discussed. The value of conducting double-tracer tests (e.g. -- Sr{sup 85} plus radio-iodinated serum albumin) was demonstrated, and correlations with excretion data were made. With further refinements the technique may ultimately become useful for certain diagnostic problems in the clinic and.for evaluating the efficacy of treatment of these disorders.","PeriodicalId":90102,"journal":{"name":"Annual progress report - University of California, Laboratory of Nuclear Medicine and Radiation Biology","volume":"449 ","pages":"1-34"},"PeriodicalIF":0.0000,"publicationDate":"1959-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":"{\"title\":\"The radioisotope osteogram-kinetic studies of skeletal disorders in humans.\",\"authors\":\"N S MACDONALD\",\"doi\":\"10.2172/129479\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Radioactive strontium can serve as a tracer to gain information concerning calcium metabolism in human subjects. Gamma-emitting Sr{sup 85} is used rather than the much more hazardous, beta-emitting Sr{sup 89} and Sr{sup 90}. (ca{sup 47} -- the ideal tracer for normal calcium -- is quite expensive and difficult to procure.) Very significant information may be obtained merely by measuring and recording the changes in radioactivity in various body areas during the first hour after intravenous injection of the bone-seeking radioisotope. This is accomplished by placing a lead-shielded gamma-scintillation detector in contact with the skin over the sites of interest and recording the activities on a scaler or ratemeter. The activity versus time curves so obtained are called radioisotope osteograms. Data were presented which indicated that Sr{sup 85} osteograms for patients afflicted with osteoporosis, Paget`s disease, tumor metastases to bone, and possibly multiple myeloma, differ significantly from those obtained from subjects with no skeletal abnormalities. Some interpretations of these deviations were discussed. The value of conducting double-tracer tests (e.g. -- Sr{sup 85} plus radio-iodinated serum albumin) was demonstrated, and correlations with excretion data were made. With further refinements the technique may ultimately become useful for certain diagnostic problems in the clinic and.for evaluating the efficacy of treatment of these disorders.\",\"PeriodicalId\":90102,\"journal\":{\"name\":\"Annual progress report - University of California, Laboratory of Nuclear Medicine and Radiation Biology\",\"volume\":\"449 \",\"pages\":\"1-34\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1959-10-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annual progress report - University of California, Laboratory of Nuclear Medicine and Radiation Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2172/129479\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annual progress report - University of California, Laboratory of Nuclear Medicine and Radiation Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2172/129479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The radioisotope osteogram-kinetic studies of skeletal disorders in humans.
Radioactive strontium can serve as a tracer to gain information concerning calcium metabolism in human subjects. Gamma-emitting Sr{sup 85} is used rather than the much more hazardous, beta-emitting Sr{sup 89} and Sr{sup 90}. (ca{sup 47} -- the ideal tracer for normal calcium -- is quite expensive and difficult to procure.) Very significant information may be obtained merely by measuring and recording the changes in radioactivity in various body areas during the first hour after intravenous injection of the bone-seeking radioisotope. This is accomplished by placing a lead-shielded gamma-scintillation detector in contact with the skin over the sites of interest and recording the activities on a scaler or ratemeter. The activity versus time curves so obtained are called radioisotope osteograms. Data were presented which indicated that Sr{sup 85} osteograms for patients afflicted with osteoporosis, Paget`s disease, tumor metastases to bone, and possibly multiple myeloma, differ significantly from those obtained from subjects with no skeletal abnormalities. Some interpretations of these deviations were discussed. The value of conducting double-tracer tests (e.g. -- Sr{sup 85} plus radio-iodinated serum albumin) was demonstrated, and correlations with excretion data were made. With further refinements the technique may ultimately become useful for certain diagnostic problems in the clinic and.for evaluating the efficacy of treatment of these disorders.